Scholarly Index
Robyn M. Scherber
Blueprint Medicines (United States); 2,207 total citations; 142 total publications; best world rank #561
Blueprint Medicines (United States)
2,207Total citations
142Total publications
23H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 858 | US 337 | 94.38 |
| Kruppel-like factors research | Lifetime | 561 | US 214 | 91.00 |
| Kruppel-like factors research | 2021-2025 | 577 | US 120 | 58.83 |